Ye Na, Wei Chen, Deng Jiaxiang, Wang Yingying, Xie Hongwen
Department of Nursing, Fourth Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Department of Emergency, Yijishan Hospital of Wannan Medical College, Wuhu, China.
Front Med (Lausanne). 2025 Feb 10;12:1532911. doi: 10.3389/fmed.2025.1532911. eCollection 2025.
Patients with acute hypoxic respiratory failure (AHRF) face life-threatening complications during tracheal intubation. Preoxygenation can enhance oxygen reserves and mitigate hypoxemia risk, but the optimal strategy remains unclear. This study aimed to identify the best preoxygenation strategy for these patients.
We conducted a network meta-analysis of studies published up to July 2024, evaluating conventional oxygen therapy (COT), high-flow nasal cannula (HFNC), non-invasive ventilation (NIV), and their combinations prior to intubation. Data were extracted and analyzed using pairwise and network meta-analysis within a Bayesian framework. Model selection was based on the deviance information criterion (DIC).
A total of 11 randomized controlled trials involving 2,874 patients were included. NIV preoxygenation significantly reduced the likelihood of SpO <80% during intubation compared to COT (RR 0.28, 95% CI 0.070-0.71). No significant differences were found in lowest SpO, complications, ICU length of stay, or mortality across preoxygenation strategies. HFNC was the most effective for reducing complications, while HFNC combined with COT or NIV showed similar effects on the lowest SpO during intubation.
Preoxygenation with HFNC appears to be the safest and most effective approach prior to intubation in patients with AHRF compared to other strategies.
PROSPERO (CRD42024565053).
急性低氧性呼吸衰竭(AHRF)患者在气管插管期间面临危及生命的并发症。预充氧可增加氧储备并降低低氧血症风险,但最佳策略仍不明确。本研究旨在确定此类患者的最佳预充氧策略。
我们对截至2024年7月发表的研究进行了网状Meta分析,评估插管前的传统氧疗(COT)、高流量鼻导管吸氧(HFNC)、无创通气(NIV)及其联合应用。在贝叶斯框架内,使用成对和网状Meta分析提取并分析数据。模型选择基于偏差信息准则(DIC)。
共纳入11项随机对照试验,涉及2874例患者。与COT相比,NIV预充氧显著降低了插管期间SpO<80%的可能性(RR 0.28,95%CI 0.070 - 0.71)。各预充氧策略在最低SpO、并发症、ICU住院时间或死亡率方面未发现显著差异。HFNC在减少并发症方面最有效,而HFNC联合COT或NIV在插管期间对最低SpO的影响相似。
与其他策略相比,HFNC预充氧似乎是AHRF患者插管前最安全、最有效的方法。
PROSPERO(CRD42024565053)